What is BromAC?
BromAC is a minimally invasive treatment for patients with peritoneal pseudomyxoma that is inoperable because of its spread, the location of the primary diagnosis, or after recurrence.
It is composed of a mixture of bromelain and acetylcysteine, substances with mucolytic properties (they dissolve mucin, the main component of peritoneal pseudomyxoma). The drug is imported from Australia through a rigorous process by the Spanish Medicines Agency, so that our patients can receive this treatment at IVOQA.
BromAC has demonstrated its efficacy in different clinical trials. Find out the results here.